Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Selectra Investment SICAV - J LaMarck Biotech

+ Add to Watchlist

SELJLBB:LX

287.78 EUR 2.40 0.84%

As of 00:59:30 ET on 05/22/2015.

Snapshot for Selectra Investment SICAV - J LaMarck Biotech (SELJLBB)

Year To Date: +22.71% 3-Month: +5.68% 3-Year: +32.16% 52-Week Range: 166.54 - 301.55
1-Month: -1.93% 1-Year: +77.02% 5-Year: - Beta vs LUXXX: 0.79

Mutual Fund Chart for SELJLBB

No chart data available.
  • SELJLBB:LX 285.38
  • 1M
  • 1Y
Interactive SELJLBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SELJLBB

SELECTRA Investment SICAV - J.Lamarck Biotech is an open-end fund incorporated in Luxembourg. The objective of the Fund is to profit from increasing share prices in the biotechnology sector. The Fund will focus on mature top tier pharmaceutical biotech companies and companies with an interesting pipeline of products in development in a single or numerous markets, like Nasdaq or NYSE.

Inception Date: 01-26-2011 Telephone: Tel. +352 26 20 22 81
Managers: -
Web Site: www.selectrasicav.com

Fundamentals for SELJLBB

NAV (on 2015-05-22) 287.78
Assets (M) (on 2015-05-22) 84.15
Fund Leveraged N
Minimum Investment 5,000.00
Minimum Subsequent Investment -

Dividends for SELJLBB

No dividends reported

Fees & Expenses for SELJLBB

Front Load 0.00
Back Load 0.00
Current Mgmt Fee -
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for SELJLBB

Filing Date: 04/30/2015
Name Position Value % of Total
Amgen Inc 53,989 7,565,141 9.800%
Gilead Sciences Inc 76,634 6,868,647 8.900%
Isis Pharmaceuticals Inc 119,053 6,021,661 7.800%
Vertex Pharmaceuticals Inc 42,519 4,674,280 6.050%
Swedish Orphan Biovitrum AB 319,656 4,581,105 5.930%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil